Liangjing W. Wang
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications
Consolidation Therapy of Probiotics With Rifaximin Prevent Relapse in Rifaximin-Responsive Diarrhea-Predominant Irritable Bowel Syndrome: A Multicenter Randomized Clinical Trial.
Journal: Journal of gastroenterology and hepatology
Published: September 14, 2025
Another ciliopathy? Uncovering the ciliary basis of biliary atresia.
Journal: Hepatology international
Published: August 20, 2025
Microbiota-dependent metabolites - New engine for T cell warriors.
Journal: Gut microbes
Published: June 30, 2025
Opportunities and challenges in applying microbiota to clinical cancer immunotherapy.
Journal: Trends in microbiology
Published: June 29, 2025
Microbiota: a dawn for cancer metastasis therapy.
Journal: Trends in molecular medicine
Published: May 11, 2025
Targeting NAT10 alleviates colonic senescence and elderly-onset colitis by disrupting N4-acetylation of DYRK1A.
Journal: Nature communications
Published: February 12, 2025
APAGE Position Statements on Green and Sustainability in Gastroenterology, Hepatology, and Gastrointestinal Endoscopy.
Journal: Journal of gastroenterology and hepatology
Published: December 18, 2024
Author Correction: Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation.
Journal: Nature communications
Published: December 10, 2024
Last Updated: 09/26/2026